May 08, 2019
Anesthesiologist Dr. David Mahjoubi, M.D. Releases First Natural Sleep Aid With Borage
Apr 18, 2019
Synergistic Therapeutics Obtains US Patent for Sublingual Ketamine Treatment for Depression
Apr 16, 2019
Relmada Therapeutics Announces Publication of REL1017 Phase 1 Studies Results
Apr 03, 2019
Gina DiGuglielmo Joins Relmada as Vice President and Head of Clinical Operations
Mar 20, 2019
Complex Regional Pain Syndrome Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Mar 14, 2019
New FDA-Approved Nasal Spray Anti-Depressant SPRAVATO(TM) Now Available in Bay Area at Palo Alto Mind Body
Mar 05, 2019
Houston based depression psychiatrist, Dr. Sandhya Prashad, M.D., tells how this new drug might save lives and cost less than expected
Mar 05, 2019
FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor's office or clinic
Mar 05, 2019
The Juvenile Bipolar Research Foundation Announces the Publication of an Article in the Journal of Psychiatry and Brain Science
Feb 15, 2019
CBS News Interviews Dr. Ashraf Hanna and Patient About Ketamine Treatments for Patients at High Suicide Risk and Depression
Feb 14, 2019
Amorsa Therapeutics Announces Notice of Allowance for U.S. Patent Covering Deuterated Norketamine and Related Compounds
Jan 10, 2019
Actify Neurotherapies Announces Former COO Of Medexpress As CEO
Jan 08, 2019
Dr. David Mahjoubi Of The Ketamine Healing Clinic Of L.A. Named 2019 Top Doctor By Los Angeles Magazine
Jan 07, 2019
Harebrained Approach To Treating Depression With Horse Tranquilizer Turns 10 Years Old
Dec 13, 2018
Nephron Pharmaceuticals Corporation Releases Opioid Free Pain Management Product: BKK
Nov 19, 2018
PAINWeekEnd in Detroit, Michigan, Offers CE/CME Education to Aid the Opioid Abuse Public Health Crisis
Oct 19, 2018
AcelRx Provides Updated Comments Following Positive FDA Advisory Committee Meeting
Oct 11, 2018
The Difference a Diagnosis Makes: How Understanding Fear of Harm Syndrome May Help Save Your Child
Oct 02, 2018
Relmada Therapeutics to Present Clinical Data on the Effect of REL-1017 on BDNF Plasma Levels
Sep 27, 2018
The VA Recognizes Ketamine As An Emergency Treatment For PTSD And Depression Patients At High Suicide Risk